Effective weight-loss strategies call for eating less food, burning more calories—or ideally, both. But for the more than 90 million Americans who suffer from obesity, a disease that contributes to conditions ranging from cancer to heart disease, behavioral change is hard to accomplish or not effective enough—which is why scientists have long sought drugs that would help people shed pounds. Yet effective, long-lasting treatments have thus far eluded them.
In a new report published in Cell, researchers in the laboratory of Jeffrey M. Friedman propose a new avenue in the search for anti-obesity drugs. Collaborating with a Princeton University team, they have found that a group of brain cells previously shown to regulate hunger also controls energy expenditure. And since our body weight depends both on the calories we consume and the energy we burn, these findings could lead to a new type of weight-loss medication that acts on both sides of the energy equation.
Thus far, most obesity research has focused on the biological mechanisms that govern how much we eat. Yet manipulating the neural circuits that control our calorie intake hasn’t led to broadly successful anti-obesity drugs. So, Marc Schneeberger Pané, a postdoctoral Kavli NSI fellow in Friedman’s lab, launched a project to investigate the processes by which we burn energy instead.
Mammals like mice and humans expend energy in many ways, and producing heat is among most important. When the ambient temperature drops, we burn more fuel to maintain a steady body temperature; when it rises, we burn less. We even possess a special form of fat tissue, known as brown fat, that is burned to produce heat directly.
Scientists knew that some populations of temperature-sensitive neurons in the hypothalamus region of the brain play a role in regulating heat production and, therefore, energy expenditure. But they did not know exactly how those neurons exerted their influence, or if other cells outside the hypothalamus might play a similar role.
The researchers began by mapping the brain regions activated by a rise in ambient temperature. They used an advanced 3D-imaging technique called iDISCO to scan the brains of mice exposed to hot temperatures, looking for signs of neuronal activity.
As expected, the team saw activity in the hypothalamus. But they also saw activity among a particular group of neurons in a part of the brainstem known as the dorsal raphe nucleus—and, to the researchers’ surprise, these happened to be the very same neurons that, just two years earlier, the lab had found to be crucial for controlling hunger.
The possibility that these cells, which the lab had previously dubbed “hunger neurons,” might regulate both hunger and energy expenditure raised the prospect that they could serve as powerful levers for managing body weight.
The researchers used sophisticated biochemical techniques to alternately turn these temperature-sensitive brainstem neurons on and off. They discovered that activating the neurons reduced the temperature of the animals’ brown fat, which is burned to generate heat, core body temperature as well. Suppressing the neurons, meanwhile, amped up heat production—and, as the scientists had shown previously, it also made the animals less hungry.
The team has already begun searching for unique receptors in these dual-purpose neurons that govern both hunger and energy expenditure. The idea is to identify targets that can be used to create novel anti-obesity drugs capable of delivering a one-two punch.
